ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.01 and traded as low as $0.0053. ProtoKinetix shares last traded at $0.0053, with a volume of 117,000 shares traded.
ProtoKinetix Stock Down 8.6%
The company has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.01.
About ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Further Reading
- Five stocks we like better than ProtoKinetix
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
